Magüi Gili
Vall d'Hebron Institut de Recerca(ES)
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Chronic Lymphocytic Leukemia Research, Chronic Myeloid Leukemia Treatments, HER2/EGFR in Cancer Research, Gene Regulatory Network Analysis
Most-Cited Works
- → Phosphatidylinositol 3-Kinase Hyperactivation Results in Lapatinib Resistance that Is Reversed by the mTOR/Phosphatidylinositol 3-Kinase Inhibitor NVP-BEZ235(2008)486 cited
- → USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma(2012)397 cited
- → Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2 + breast cancer patients(2011)325 cited
- → A unified design space of synthetic stripe-forming networks(2014)151 cited
- → A split intein T7 RNA polymerase for transcriptional AND-logic(2014)55 cited
- → Abstract 22: Cyclin E amplification, a novel mechanism of resistance to trastuzumab in HER2 amplified breast cancer(2010)1 cited
- → Supplementary Figure 3 from Phosphatidylinositol 3-Kinase Hyperactivation Results in Lapatinib Resistance that Is Reversed by the mTOR/Phosphatidylinositol 3-Kinase Inhibitor NVP-BEZ235(2023)
- → Supplementary Table 2 from Phosphatidylinositol 3-Kinase Hyperactivation Results in Lapatinib Resistance that Is Reversed by the mTOR/Phosphatidylinositol 3-Kinase Inhibitor NVP-BEZ235(2023)
- → Supplementary Figure 2 from Phosphatidylinositol 3-Kinase Hyperactivation Results in Lapatinib Resistance that Is Reversed by the mTOR/Phosphatidylinositol 3-Kinase Inhibitor NVP-BEZ235(2023)